Immune-Onc Therapeutics Inc   Report issue

For profit Phase 1
Founded: Palo Alto CA United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04372433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Immune-Onc Therapeutics | Immune-Onc Therapeutics Inc